In Obtaining Strong Price From BMS, Medarex Also Ameliorates Significant Pipeline Pressure
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol's acquisition offer of $16 per share is certainly generous, but Medarex has a lengthy and promising pipeline to offer and one which would have needed deep pockets down the road.